Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 31:9:2017.
doi: 10.3389/fpsyg.2018.02017. eCollection 2018.

Accelerated rTMS: A Potential Treatment to Alleviate Refractory Depression

Affiliations

Accelerated rTMS: A Potential Treatment to Alleviate Refractory Depression

Chris Baeken. Front Psychol. .

Abstract

Three decades of clinical research on repetitive transcranial magnetic stimulation (rTMS) has yielded one clear treatment indication in psychiatry for major depression disorder (MDD). Although the clinical response equals the standard treatment algorithms, the effect sizes on the beneficial outcome remain rather modest. Over the last couple of years, to improve the efficacy in resistant depression, two new avenues have been developed: personalization and intensifying rTMS treatment. For the latter, we retrospectively compared accelerated high-frequency rTMS (arTMS) with accelerated intermittent theta burst stimulation (aiTBS) in the refractory depressed state. Although the clinical efficacy was not significantly different between both protocols, our observations substantiate the potential of the accelerated stimulation to shorten the treatment duration from the depressed state to the response state. Any time gain from the depressed state to the recovered state is in the patients' interest.

Keywords: HF-rTMS; accelerated rTMS; major depressive disorder; refractory MDD; theta-burst stimulation.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Graphical representation of the HDRS scores (mean and standard deviations) at baseline (T1), after 1-week (T2), and after 2-weeks of stimulation (T3) for aHF-rTMS and aiTBS treatment separately.

Similar articles

Cited by

References

    1. Baeken C., Marinazzo D., Everaert H., Wu G. R., Van Hove C., Audenaert K., et al. (2015). The impact of accelerated HF-rTMS on the subgenual anterior cingulate cortex in refractory unipolar major depression: insights from 18FDG PET brain imaging. Brain Stimul. 8 808–815. 10.1016/j.brs.2015.01.415 - DOI - PubMed
    1. Baeken C., Vanderhasselt M. A., Remue J., Herremans S., Vanderbruggen N., Zeeuws D., et al. (2013). Intensive HF-rTMS treatment in refractory medication-resistant unipolar depressed patients. J. Affect. Disord. 151 625–631. 10.1016/j.jad.2013.07.008 - DOI - PubMed
    1. Bakker N., Shahab S., Giacobbe P., Blumberger D. M., Daskalakis Z. J., Kennedy S. H., et al. (2015). rTMS of the dorsomedial prefrontal cortex for major depression: safety, tolerability, effectiveness, and outcome predictors for 10 Hz versus intermittent theta-burst stimulation. Brain Stimul. 8 208–215. 10.1016/j.brs.2014.11.002 - DOI - PubMed
    1. Berlim M. T., van den Eynde F., Tovar-Perdomo S., Daskalakis Z. J. (2014). Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol. Med. 44 225–239. 10.1017/S0033291713000512 - DOI - PubMed
    1. Berman R. M., Narasimhan M., Sanacora G., Miano A. P., Hoffman R. E., Hu X. S., et al. (2000). A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol. Psychiatry 47 332–337. 10.1016/S0006-3223(99)00243-7 - DOI - PubMed